Latest filing published 09 Mar 2015 for Jazz Pharmaceuticals plc, €257k.
No signal scores available.
Filings by Jeffrey K. Tobias span 2 companies, the busiest being Jazz Pharmaceuticals plc and NeurogesX Inc. In total, 54 filings cover trades dated from 25 November 2009 to 5 March 2015.
The open-market record consists of 27 sales worth €5.4M, with no purchase. Other entries cover 9 share grants and 18 option exercises. So far in 2015, the count stands at no purchases and 2 sales.
The latest filing, published on 9 March 2015, reports a share grant of €257k in Jazz Pharmaceuticals plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations